Scientific Publication

Kanazawa University researchers use high-speed microscopy to reveal how DNA's physical structure dictates its vulnerability to enzymatic destruction.

A groundbreaking SRI Education study reveals that older students still need phonics, signaling a major shift in how districts allocate literacy resources.

New clinical data reveals that combining motion preservation with anatomical alignment significantly outperforms traditional spinal fusion outcomes.

Marathon Fusion proposes a novel supply chain hack using a stable precursor to solve the multi-decade shortage of a promising cancer-treating radioisotope.

Applying advanced pharmacokinetic simulations, Luye Pharma is challenging a $2.9 billion market by proposing flexible dosing strategies for its antipsychotic ERZOFRI.

Ophirex's Phase 2 trial missed its primary goals, but subgroup data and a rare FDA pathway could salvage a game-changing oral snakebite treatment.

Carnegie Mellon just dropped a roadmap of 37 cyber research priorities. Can the Pentagon adopt machine-speed defenses before adversaries exploit legacy systems?

The Cigna Group’s latest research proves that paid volunteer time isn’t just a PR stunt—it’s a vital tool for health, retention, and AI-era skill building.

When a hurricane crippled IV fluid supplies, a NY hospital was forced to adapt. The result was a stunning discovery: less fluid meant fewer complications.

For 50 years, sales strategy has been built on fear of loss. New biometric research reveals why empowering buyers with control is 31% more effective.

Beyond predicting structures, MoleculeMind's QuantaMind simulates entire chemical reactions, offering a dynamic view that could slash R&D costs in pharma.

Singaporean scientists are reprogramming immune cells with magnetic fields, eradicating tumors in preclinical trials and offering hope for a future without chemo.

A new study reveals an mRNA flu vaccine sustains immune responses for months, a breakthrough that could lead to multi-season protection and end the annual flu shot.

CSL Seqirus's new flu shot combines three proven technologies. A landmark Lancet study validates its strategic R&D investment in the senior healthcare market.

Meta and startup Panmnesia are using CXL to erase the boundaries between racks, creating a unified computing fabric to power tomorrow's giant AI models.

A breakthrough in proteomics allows Nautilus Biotechnology to map individual disease-linked proteins, promising to revolutionize diagnostics and drug discovery.

Thai researchers are turning fat into insulin-producing cells to cure pet diabetes. But can this breakthrough navigate the path from lab to leash?

A new wave of at-home neuromodulation devices is dismantling old treatment paradigms. We explore the shift from clinic to living room and what it means for patients and investors.

A landmark report reveals arthritis isn't just a health issue; it's a massive economic drain poised to grow, costing Canada nearly 5% of its GDP annually.

Designed to rehabilitate impaired physicians, Physician Health Programs are now accused of being punitive traps, with claims of false diagnoses and profiteering.